LONDON, Oct. 25, 2022 (GLOBE NEWSWIRE) -- Promatix, a London-based oncology drug discovery and development company that uses multi-omics to identify novel therapeutics, today announced a collaboration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback